Advertisement

The Scientist

» ALS

Most Recent

image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.

2 Comments

image: Beneficial Stats

Beneficial Stats

By | March 1, 2015

Statisticians who normally crunch numbers to forecast trends in the food-service industry turn their attention to bettering treatment of ALS.

0 Comments

The ALS Association has raised more than $100 million in donations through a charity campaign that went viral. How should that money be spent?

1 Comment

image: Ice Bucket Challenge Irony

Ice Bucket Challenge Irony

By | August 25, 2014

Several US legislators who voted in favor of a bill that cut federal funding for ALS research have taken the chilly plunge for charity.

4 Comments

image: Non-coding Repeats Cause Peptide Clumps

Non-coding Repeats Cause Peptide Clumps

By | February 7, 2013

Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.

0 Comments

image: Medical Mavericks

Medical Mavericks

By | July 1, 2012

ALS patients take their fate into their own hands, self-administering an unapproved chemical and collating their results online.

11 Comments

Advertisement

Popular Now

  1. How Fats Influence the Microbiome
  2. Hearing Help
    Features Hearing Help

    For decades, the only remedies for hearing loss were devices such as hearing aids or cochlear implants. Now, the first pharmaceutical treatments may be on the way.
     

  3. Psychology’s Failure to Replicate
  4. The Great Big Clean-Up
    Features The Great Big Clean-Up

    From tossing out cross-contaminated cell lines to flagging genomic misnomers, a push is on to tidy up biomedical research.

Advertisement
Bina
Bina
Advertisement
Life Technologies